Potential Agents of Bioterrorism: Historical Perspective and an Overview

Bioterrorism Preparedness: Medicine - Public Health - Policy

Volumn , Issue , 2006, Pages 1-31

  Khardori, Nancy ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial Rickettsial agents of bioterrorism; Biological toxins for bioterrorism; Bioterrorism preparedness; Categorization and prioritization; Development of modern biological weapons; Emerging threats; Historical perspective; Potential agents of bioterrorism; Viral agents of bioterrorism

Indexed keywords

EID: 84878496592     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527608133.ch1     Document Type: Chapter

References (60)

1. Zinsser, H. 1963 Rats, lice and history. Boston, MA, The Atlantic Monthly Press by Little Brown and Company.
2. Diamond, J. 1999 Guns, germs and steel. New York, NY: www/Norton and Co.
3. Heyman, D. 2000 The global infectious disease threat and its implication for the United States. National Intelligence Council; Publication NIEW Washington D. C. 99-170.
4. Christopher, G. W., Cieslak, T. J., Pavlin, J. A. et al. 1997 Biological warfare. A historical perspective. JAMA, 278:412-417.
5. Poupard, J. and Miller, L. 1992 History of biological warfare. Catapults to capsomers. Ann NY Acad Sci., 666:9-20.
6. Eitzen, E. M. and Takafuji, E. T. 1997 Historical overview of biological warfare. In: Sidell FR, Takafuju EF, Franz DR, editors. Medical aspects of chemical and biological warfare. Textbook of Military Medicine Part I, Warfare, Weaponry and the Casualty. Borden Institute; Washington D. C. 415-423.
7. Derbes, V.J. 1966 De Mussis and the great plague of 1348. A forgotten episode of bacteriological warfare. JAMA 96:179-182.
8. Hopkins, D. R. 1983. Princes and peasants. Smallpox in history. University of Chicago Press, Chicago, Illinois.
9. Hugh-Jones, M. 1992 Wickham Steed and German biological warfare research. Intelligence and National Security 7:379-402.
10. Geissler, E. 1986 Biological and toxin weapons: Research, development and use from the Middle Ages to 1945. SIPRI Chemical and Biological Warfare Studies. No. 16. Oxford University Press Inc. New York, New York.
11. Harris, S. 1992 Japanese biological warfare research on humans: A case study of microbiology and ethics. Ann NY Acad Sci, 666:21-52.
12. Nitscherlich, A., Mielke, F. 1983 Medizin ohne menschlichkeit: Dokuments des Nurnberger Arzteprozesses. Frankfurt am Main, Germany. Fischer Taxchenbuchverlag.
13. Manchee, R. J., Steward, R. 1988 The decontamination of Gruinard Island. Chem. Br 24:690-691.
14. Davis, C. J. 1999 Nuclear blindness: An overview of the biological weapons program of the former Soviet Union and Iraq. Emerg Inf Dis, 5:509-512.
15. Stubbs, M. 1962 Has the West an Achilles heel: Possibilities of biological weapons. NATO's Fifteen Nations. June/July, 7:94-99.
16. Henderson, D. A. 1998 Bioterrorism as a public health threat. Emerging Infectious Diseases, 4:488-492.
17. Henderson, D. A. 2001 Strengthening global preparedness for defense against infectious diseases threats. Hearing on the Threat of Bioterrorism and the Spread of Infectious Disease, 1st Session, 107th Congress.
18. Zalinskas, R. A. 1997 Iraq's biological weapons? The past or future? JAMA, 278:418-424.
19. Rorberts, B. 1993 New challenges and new policy priorities for the 1990's. In: Biologic weapons; weapons of the future. Center for Strategic and International Studies, Washington, D. C.
20. Bartlett, J. G. 1999 Update in infectious diseases. Ann of Inter Med 131:273-280.
21. Carus, W. S. 1999 Bioterrorism and biocrimes: The illicit use of biological agents in the 20th century. Center for Counterproliferation Research, National Defense University, Washington, D. C.
22. Henderson, D. A. 1999 The looming threat of bioterrorism. Science, 283:1279-1282.
23. Kortepeter, M. G., Parker, G. W. 1999 Potential biological weapons threats. Emerg Inf Dis 5:523-527.
24. Relman, D. A. and Olson, J. E. 2001 Bioterrorism preparedness: what practitioners need to know. Infect. Med. 18:497-514.
25. Tucker, J. B. 1999 Historical trends related to bioterrorism: an empirical analysis. Emerg. Inf. Dis 5:498-504.
26. Khardori, N. and Kanchanapoom, T. 2005 Overview of biological terrorism: Potential agents and preparedness. Clinic Microb News 27:1-8.
27. Stewart. C. 2001 Toxins and biowarfare in biological warfare: Preparing for the unthinkable emergency. Topics in Emergency Medicine. Am. Health Consult, Vol II, Atlanta, Georgia
28. Hawley, R. J. and Eitzen, E. M., Jr. 2001 Biological weapons-a primer for microbiologists. Annu. Rev. Microbiol 55:235-253.
29. Richards, C. F. et al. 1999 Emergency physicians and biological terrorism. Ann Emerg. Med. 34:182-190.
30. Miller, J. M. 2001 Agents of bioterrorism: preparing for bioterrorism at the community health care level. Infect. Dis. Clin. N. Am. 15:1127-1156.
31. Beeching, N. J., Dance, D. A., Miller, A. R., et al. 2002 Biological Warfare and bioterrorism. BMJ 324:336-339.
32. Danzig, R. and Berkowsky, P. B. 1997 Why should we be concerned about biological weapons. JAMA 278:431-432.
33. Kaufmann, A. F., Meltzer, M. I. and Schnid, G. P. 1997 The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable? Emerg Inf. Dis 3:83-94.
34. Departments of Army, Navy and Air Force 1996 NATO Handbook on the Medical Aspects of NBC defensive operations. The Department of Defense., Washington, D. C.
35. Khan, A. S., Moise, S. A., and Lillibridge, S. 2000 Public health preparedness for biological terrorism in the USA. Lancet 356:1179-1182.
36. Centers for Disease Control and Prevention. 2000. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup, MMWR Vol. 49 No. RR-4.
37. Rotz, L. D., Khan, A. S., Lillibridge, S. R. Ostroff, S. M. and Hughes, J. M. 2002 Report summary. Public Health Assessment of Potential biological terrorism agents. Emerg Inf Dis 8:225-229.
38. USAMRIID's Medical Management of biological Casualties Handbook. 2004 U. S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland. 1-117.
39. Pappas, G., Akritidis, N., Bosilkovski, M. And Tsianos, E. 2005 Brucellosis N Engl J Med 352:2325-2236.
40. CDC, Division of Bacterial and Mycotic Diseases. 2002 Glanders. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/glanders_g.htm.
41. CDC, Division of Bacterial and Mycotic Diseases. 2002 Melioidosis (Bukholderia pseudomallei) http?//www.cdc.gov/ncidod/dbmd/diseaseinfo/melioidosis_g.htm
42. Deitchman, S. and Sokas, R. 2001 Glanders in a military research microbiologist. N Engl J Med, 345:1644.
43. Schlossberg, D. 2005. Chlamydophila (Chlamydia) psittaci (Psittacosis) in Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Churchill, Livingstone, Philadelphia, Pennsylvania. 2256-2258.
44. Dupont, H. T., Raoult, D., Brouqui, P., et. al. 1992 Epidemiologic features and clinical presentation of acute Q Fever in hospitalized patients: 323 French cases. Am. J Med 93:427-434.
45. Raoult, D. and Walker, D.H. 2005 Rickettsia prowazekii (Epidemic or Louse-Borne typhus) in Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Churchill, Livingstone, Philadelphia, Pennsylvania 2303-2306.
46. Fry, A. M., Braden, C. R., Griffen, P. M. and Hughes, J. M. 2005 Foodborne disease in Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Churchill, Livingstone, Philadelphia, Pennsylvania 1286-1301.
47. Whitney, R. J. and Gnann, J. W. 2002 Viral encephalitis: familiar infections and emerging pathogens. The Lancet 359:507-513.
48. Ostroff, S. M., McDade, J. E., LeDuc, J. W., Hughes, J. M. 2005 Emerging and Reemerging Infectious Disease Threats in Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Churchill, Livingstone, Philadelphia, Pennsylvania 173-192.
49. Borio, L., Inglesby, T., Peters, C. J., et. al. 2002 Hemorrhagic fever viruses as biological weapons. Medical and Public Health management. JAMA 287:2391-2411.
50. USAMRIID's Medical Management of biological Casualties Handbook. 2004 U. S. Emerging threats and future biological weapons. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland. 100-108.
51. Oxford, J. S. 2005 Preparing for the first influenza pandemic of the 21st century. The Lancet 5:129-131.
52. Osterholm, M. T. 2005 Preparing for the next pandemic. N Engl J Med 352:1839-1842.
53. Hien, T., de Jong, M. and Farrar, J. 2005 Avian influenza-A challenge to global health care structures. N Engl J Med 351:2363-2365.
54. Olofsson, S., Kumlin, U., Dimock, K. and Amberg, N. 2005 Avian influenza and sialic acid receptors: more than meets the eye? Lancet Infect Dis 5:184-188.
55. Editorial 2004 Reflection and Reaction SARS, emerging infections and bioterrorism preparedness. Lancet Inf Dis 4:483-484.
56. Groneberg, D. A., Poutanen, S. M., Low, D. E., Lode, H. Welte, T. and Zabel, P. 2005 Treatment and vaccines for severe acute respiratory syndrome. Lancet Inf Dis 5:147-155.
57. Svoboda, T., Henry, B., Shulman, L., et al.. 2004 Public Health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto. N Engl J Med 350:2352-2361.
58. Molyneux, D.H. 2004 "Neglected" diseases but unrecognized successes-Challenges and opportunities for infectious disease control. The Lancet 364:380-383.
59. Witt, C. J. and Malone, J. C. 2005 A veterinarian's experience of the spring 2004 avian influenza outbreak in Laos. Lancet Inf Dis 5:143-145.
60. Gosden, C. and Gardener, D. 2005 Weapons of mass destruction-threats and responses. BMJ 331:397-400.